No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SYK240816C330000
- 16.00
- +4.70+41.59%
15min DelayClose Jul 19 16:00 ET
16.00High16.00Low
16.00Open11.30Pre Close1 Volume71 Open Interest330.00Strike Price1.60KTurnover29.81%IV1.48%PremiumAug 16, 2024Expiry Date10.95Intrinsic Value100Multiplier25DDays to Expiry5.05Extrinsic Value100Contract SizeAmericanOptions Type0.6909Delta0.0131Gamma19.21Leverage Ratio-0.2174Theta0.1537Rho13.27Eff Leverage0.3191Vega
Intraday
- 5D
- Daily
News
CereVasc Announces Appointments of New Directors
Medical Device Leaders Shlomi Nachman and Timothy Scannell to join Board of DirectorsBOSTON, July 16, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel
Stryker Is Maintained at Buy by BTIG
Stryker Is Maintained at Buy by
Express News | Stryker Corporation : Morgan Stanley Raises Target Price to $350.00 From $345.00
Morgan Stanley Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $350
Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp(SYK.US)$ with a hold rating, and adjusts the target price from $345 to $350.According to TipRanks data, the analyst has a success rate of 39
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $372
BTIG analyst Ryan Zimmerman maintains $Stryker Corp(SYK.US)$ with a buy rating, and adjusts the target price from $369 to $372.According to TipRanks data, the analyst has a success rate of 46.6% and
Express News | Stryker Completes Acquisition of Artelon, Inc.
Comments
The recent insider sale of Stryker shares at the current price is viewed negatively. However, high insider ownership is seen positively, suggesting management's consideration for shareholders. Yet, the absence of insider buying over the past year is worrisome.
The EPS decline doesn't align with share price changes, indicating other factors. Management might be prioritizing revenue growth over EPS. The company's recent performance improvement suggests potential business momentum.
Read more